ACQUIREDT+7
Agomab Therapeutics NV · NASDAQ
+2,000 sh · $17.1K
Filed 7 Oct 2026SEC Form 4view source
- ACQUIREDT+7
Agomab Therapeutics NV · NASDAQ
+5,000 sh · $42.9K
Filed 7 Oct 2026SEC Form 4view source - ACQUIREDT+7
Agomab Therapeutics NV · NASDAQ
+3,000 sh · $26.0K
Filed 7 Oct 2026SEC Form 4view source